针对B细胞恶性瘤的免疫疗法中的γδ T细胞
Léa Rimailho1, Carla Faria1, Marcin Domagala1
1Cancer Research Center of Toulouse (CRCT), UMR1037 Inserm-Univ. Toulouse III Paul Sabatier-ERL5294 CNRS, Toulouse, France.
Frontiers in immunology
|July 10, 2023
概括
玛三角T细胞在治疗B细胞恶性瘤方面表现有前途,提供了新的免疫疗法选择. 研究探讨了增强其抗瘤活性以改善患者治疗结果的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞疗法细胞疗法
背景情况:
- 尽管目前使用化学疗法和抗CD20抗体等疗法,但B细胞恶性瘤经常复发.
- 现有的治疗方法产生混合的结果,突出需要新的治疗策略.
- 基于免疫细胞的疗法,特别是涉及T细胞的疗法,正在成为有前途的途径.
研究的目的:
- 审查利用马三角 (γδ) T 细胞治疗B细胞恶性瘤的策略.
- 探索激活,扩展和基因修饰 γδ T 细胞用于免疫治疗的方法.
- 讨论在B细胞癌患者中使用γδ T细胞的采用细胞疗法的潜力.
主要方法:
- 关于γδT细胞生物学和免疫治疗的当前文献的综述.
- 对 γδ T 细胞激活和瘤向策略的分析.
- 对 γδ T 细胞扩张和基因修饰的协议的评估.
- 评估采用的细胞疗法方法与自身和异性 γδ T 细胞.
主要成果:
- γδ T 细胞具有功能性可塑性和固有的抗瘤特性,使其适合用于癌症免疫治疗.
- 在包括B细胞恶性瘤在内的各种疾病中,gδ T细胞的存在和多样性提供了治疗操纵潜力.
- 目前正在开发一些涉及抗体和药物组合的策略,以及采用细胞疗法.
结论:
- 基于 γδ T T 细胞的免疫疗法代表了对B细胞恶性瘤的有希望的方法.
- 优化的扩张,激活和基因修饰 γδ T 细胞是成功治疗应用的关键.
- 工程或未经处理的 γδ T 细胞的采用转移有可能克服B细胞癌症的治疗耐药性和复发.
相关概念视频
Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cytotoxic T Cells-mediated Immune Response
985
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
985
T Cell Types and Functions
1.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.1K
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Cancer Vaccines
419
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
419


